Cannabis Use and Misuse in Older Adults

Khoury, Rita; Maliha, Peter; Ibrahim, Roy

doi:10.1016/j.cger.2021.07.003

Cited by 9 publications

(3 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As previously discussed, the most common substance of use in this population is alcohol. Recently, the consumption of marijuana among older adults has significantly increased (Khoury et al , 2022). Other commonly used substances include opioids, nicotine, and prescription drugs such as antimuscarinics and benzodiazepines.…”

Section: Intertwining Relationship Between Neurocognitive Disorders A...mentioning

confidence: 99%

“…When activated, these receptors reduce excitotoxicity, phosphorylation and plaque formation, all neuropathological hallmarks of Alzheimer’s disease (Martín-Moreno et al , 2012; Bilkei-Gorzo et al , 2017; Sarne et al , 2018; Suliman et al , 2018). Clinically, cannabis use in older adults has many physical and mental health adverse effects (Khoury et al , 2022). It appears to exacerbate age-related cognitive impairment.…”

Section: Intertwining Relationship Between Neurocognitive Disorders A...mentioning

confidence: 99%

See 1 more Smart Citation

Neurocognitive and substance use disorders in older adults: challenges and evidence

Agrawal

Sawaya

Ojeahere

et al. 2022

ADD

View full text Add to dashboard Cite

Purpose This study aims to review the presentation of substance use disorders in older adults, how addiction intertwines with neurocognitive disorders and how to approach this vulnerable population. Design/methodology/approach Electronic data searches of PubMed, Medline and the Cochrane Library (years 2000–2021) were performed using the keywords “neurocognitive,” “dementia,” “substance use,” “addiction,” “older adults” and “elderly.” The authors, in consensus, selected pivotal studies and conducted a narrative synthesis of the findings. Findings Research about substance use disorders in older adults is limited, especially in those with superimposed neurocognitive disorders. Having dual diagnoses can make the identification and treatment of either condition challenging. Management should use a holistic multidisciplinary approach that involves medical professionals and caregivers. Originality/value This review highlights some of the intertwining aspects between substance use disorders and neurocognitive disorders in older adults. It provides a comprehensive summary of the available evidence on treatment in this population.

show abstract

Section: Intertwining Relationship Between Neurocognitive Disorders A...mentioning

confidence: 99%

Section: Intertwining Relationship Between Neurocognitive Disorders A...mentioning

confidence: 99%

Neurocognitive and substance use disorders in older adults: challenges and evidence

Agrawal

Sawaya

Ojeahere

et al. 2022

ADD

View full text Add to dashboard Cite

show abstract

“… 4 - 7 Older individuals are increasingly turning to cannabis to deal with chronic pain and other issues such as insomnia. 8 Yet there is limited evidence about the effects of cannabis for people living with rheumatic conditions. 1 Therefore, both clinicians and individuals living with rheumatic conditions face uncertainties and unanswered questions.…”

Section: Introductionmentioning

confidence: 99%

Perceptions of Cannabis Use: A Qualitative Descriptive Study of Rheumatology Patients

Olson,

Brophy,

Turk

et al. 2023

J Prim Care Community Health

View full text Add to dashboard Cite

Introduction/Objectives: Some rheumatology patients use or contemplate using cannabis, however, may not be transparent about use with their providers. The objective of this qualitative descriptive study was to describe beliefs, perceptions, and learning needs of adults with rheumatic conditions regarding the use of cannabis products. Methods: Purposive sampling was conducted through a rheumatology clinic and sought participants who were using or thinking about using cannabis. Two online focus groups based on cannabis use patterns (non-users and users) were conducted separately. Interviews were audio recorded and transcribed. Three research team members read the transcripts independently to identify initial codes and themes. Data saturation was reached with the interviews. Results: We recruited 12 participants between 52 and 85 years old. The first theme was pain and desperation. Stigma was the second theme with a perception of physician opposition to cannabis, and the reluctance of many participants to discuss cannabis use with physicians. The final theme was a need for information and a general lack of trustworthy and credible sources. Users were willing to try cannabis even if they still had questions. Conclusion: Rheumatology patients are open to using cannabis due to the burden and suffering associated with pain. They remain silent on the topic, however, because of stigma and lack of engagement from health care professionals, particularly physicians. Patients voiced a strong need for information regarding cannabis and want healthcare providers to initiate discussion. These findings are clinically relevant to the management of rheumatic conditions and the promotion of therapeutic relationships.

show abstract